Author

Jose M Muñoz-Felix

Profesor Contratado Doctor. Universidad de Salamanca. Dpto. Bioqu

Biography

Working in the Renal and Cardiovascular Research Unit under the Department of Physiology and Pharmacology in the University of Salamanca, Salamanca and went to Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain in the Institute Queen Sophie for Renal Research, Salamanca, Spain.
Title
Cited by
Year
TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?
JM Munoz-Felix, M Gonzalez-Nunez, C Martinez-Salgado, ...Pharmacology & therapeutics 156, 44-58, 2015201
80
2015
The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?
M González-Núñez, JM Muñoz-Félix, JM López-NovoaBiochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832 (10 …, 2013201
71
2013
ALK1-Smad1/5 signaling pathway in fibrosis development: friend or foe?
JM Munoz-Felix, M Gonzalez-Nunez, JM Lopez-NovoaCytokine & growth factor reviews 24 (6), 523-537, 2013201
69
2013
Cancer burden is controlled by mural cell-β3-integrin regulated crosstalk with tumor cells
PP Wong, JM Muñoz-Félix, M Hijazi, H Kim, SD Robinson, ...Cell 181 (6), 13-1363. e21, 2020202
46
2020
L-Endoglin overexpression increases renal fibrosis after unilateral ureteral obstruction
B Oujo, JM Munoz-Felix, M Arevalo, E Nunez-Gomez, L Perez-Roque, ...PLoS One 9 (10), e1105, 2014201
36
2014
Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth
T Lechertier, LE Reynolds, H Kim, AR Pedrosa, J Gómez-Escudero, ...Nature Communications 11 (1), 2810, 2020202
35
2020
The role of endoglin in kidney fibrosis
JM Muñoz-Felix, B Oujo, JM Lopez-NovoaExpert reviews in molecular medicine 16, e18, 2014201
35
2014
Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro
JM Muñoz-Félix, C Cuesta, N Perretta-Tejedor, M Subileau, ...Cellular signalling 28 (9), 1252-1261, 2016201
33
2016
ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts
JM Munoz-Felix, N Perretta-Tejedor, N Eleno, JM Lopez-Novoa, ...Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1843 (6), 1111-1122, 2014201
31
2014
Overcoming the lack of oral availability of cyclic hexapeptides: design of a selective and orally available ligand for the Integrin αvβ3
M Weinmüller, F Rechenmacher, U Kiran Marelli, F Reichart, TG Kapp, ...Angewandte Chemie International Edition 56 (51), 16405-16409, 2017201
30
2017
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy
JM Muñoz-Félix, JM López-Novoa, C Martínez-SalgadoKidney International 85 (2), 319-332, 2014201
26
2014
Impaired erythropoietin synthesis in chronic kidney disease is caused by alterations in extracellular matrix composition
G Olmos, JM Muñoz‐Félix, I Mora, AG Müller, MP Ruiz‐Torres, ...Journal of Cellular and Molecular Medicine 22 (1), 302-314, 2018201
24
2018
Novel pure αVβ3 integrin antagonists that do not induce receptor extension, prime the receptor, or enhance angiogenesis at low concentrations
J Li, Y Fukase, Y Shang, W Zou, JM Muñoz-Félix, L Buitrago, ...ACS Pharmacology & Translational Science 2 (6), 387-401, 202
19
2019
Overexpression of the short endoglin isoform reduces renal fibrosis and inflammation after unilateral ureteral obstruction
JM Munoz-Felix, L Perez-Roque, E Nunez-Gomez, B Oujo, M Arevalo, ...Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 62 (9 …, 2016201
18
2016
Absence of K‐Ras reduces proliferation and migration but increases extracellular matrix synthesis in fibroblasts
JM Muñoz‐Félix, I Fuentes‐Calvo, C Cuesta, N Eleno, P Crespo, ...Journal of Cellular Physiology 231 (10), 2224-2235, 2016201
13
2016
Cardiotrophin‐1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease
N Perretta‐Tejedor, JM Muñoz‐Félix, A Düwel, Y Quiros‐Luis, ...Acta Physiologica 226 (2), e13247, 2019201
11
2019
The Dual Effect of the BMP9–ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?
The Dual Effect of the BMP–ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?B Ayuso-Íñigo, L Méndez-García, M Pericacho, JM Muñoz-FélixCancers 13 (21), 5412, 2021202
9
2021
Improved immunotherapy efficacy by vascular modulation
EL Newport, AR Pedrosa, A Njegic, KM Hodivala-Dilke, JM Muñoz-FélixCancers 13 (20), 5207, 2021202
8
2021
Dissecting the involvement of ras GTPases in kidney fibrosis
JM Muñoz-Félix, C Martínez-SalgadoGenes 12 (6), 800, 2021202
5
2021
Functional specific roles of H‐ras and N‐ras. A proteomic approach using knockout cell lines
L Ferreira, I Fuentes‐Calvo, JM Muñoz‐Félix, C Muñiz‐Martín, ...Electrophoresis 33 (9‐10), 1385-1396, 2012201
4
2012

Referred From: https://scholar.google.com/citations?user=9KFb2McAAAAJ&hl=es

Cited by
Citations 651
h-index 15
i10-index 17
Recommended Journals
Open Access Journals